Chinese Medical Sciences Journal ›› 2015, Vol. 30 ›› Issue (1): 51-55.doi: 10.1016/S1001-9294(15)30009-2

• ORIGINAL ARTICLE • Previous Articles     Next Articles

Effects of Sunitinib Malate on Growth of Human Bladder Transitional Cell Line T24 In Vitro

Jin Wen1, Han-zhong Li1, *, Zhi-gang Ji1, Jing Jin2   

  1. 1 Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China; 2 Department of Pharmacy, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
  • Published:2015-04-02 Online:2015-04-02
  • Contact: **Corresponding author Tel: 86-10-69156073, E-mail:

Objective To investigate the growth-inhibitory effect of sunitinib malate on human bladder transitional cell carcinoma (TCC) in vitro.
Methods Human bladder TCC cell line T24 was cultured and exposed to graded concentrations of sunitinib malate for 72 hours in vitro to determine the sensitivities to drug. Cell viability was measured by MTT assay. Cell apoptotic morphology was observed by fluorescence microscope following DAPI staining. Band expressions of Fas, Fas ligand, poly (ADP-ribose) polymerase (PARP) and β-actin were analyzed by Western blot. Wound healing process of T24 cells exposed to sunitinib malate was assayed.
Results Sunitinib malate exerted a concentration-dependent and time-dependent inhibitory effect on the T24 cell lines. Fluorescence microscopy showed that small vacuoles appeared in the nuclei of T24 cells and the vacuoles were bigger with higher drug concentrations. The expressions of Fas ligand and PARP in T24 cells treated with sunitinib malate exhibited a concentration-dependent increase. Moreover sunitinib malate suppressed the wound healing process in a concentration-dependent manner.
Conclusion Sunitinib malate exerted marked inhibitory activity against bladder cancer cell line T24.

Key words: sunitinib, bladder cancer, proliferation

Funding: △Supported by the Beijing Natural Science Foundation (7102128)

Copyright © 2021 Chinese Academy of Medical Sciences.  京公安备110402430088  京ICP备06002729号-1  Powered by Magtech.

Supervised by National Health Commission of the People's Republic of China

9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China

Tel: 86-10-65105897  Fax:86-10-65133074 


Copyright © 2018 Chinese Academy of Medical Sciences

All right reserved.

京公安备110402430088  京ICP备06002729号-1